CLIGAVYX
NDC 83831-159, fulvestrant, injection, from Avyxa Pharma, LLC.
- Product NDC
- 83831-159
- Status
- Listed
- Labeler
- Avyxa Pharma, LLC
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83831-159 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT250 mg/5mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83831-159-02 | 83831015902 | 2 SYRINGE, GLASS in 1 CARTON (83831-159-02) / 5 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e20d8ca3-8837-4003-8b01-1ebec342062a
Use it
Look up 83831-159 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83831-159 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83831-159. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.